Khaled Abouzid

Cited by

	All	Since 2019
Citations	4194	2607
h-index	37	30
i10-index	91	74

620

310

155

465

19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202415 16 16 13 26 12 23 33 44 37 40 53 70 70 92 123 131 144 184 200 222 316 387 485 604 589 222

Public access

View all

10 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Deena S. LasheenDepartment of Pharmaceutical Chemistry, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Dalal Abou El EllaFaculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Eman DoklaFaculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Sandra N MilikLecturer assistant, department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ainshams UniversityVerified email at pharma.asu.edu.eg
Amal Kamal Abdel-AzizAssociate Professor of Pharmacology & Toxicology, ASU and Postdoctoral Pharmacologist, IEO, ItalyVerified email at pharma.asu.edu.eg
Nahla FaragProfessor of Pharmaceutical Medicinal Chemistry, Misr International UniversityVerified email at miuegypt.edu.eg
Ashraf AbadiProfessor, Former Dean, Faculty of Pharmacy and Biotechnology, German University in CairoVerified email at guc.edu.eg
Nadia Abdalla KhalilProfessor of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo UniversityVerified email at pharma.cu.edu.eg
Ahmed EsmatProfessor of Pharmacology & Toxicology, Faculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
samar mowafyMisr International UniversityVerified email at miuegypt.edu.eg
Khairia M. YoussefFuture University in EgyptVerified email at fue.edu.eg
Feng WangProfessor of Chemistry, Swinburne University of Technology, AustraliaVerified email at swin.edu.au
Moustafa El-ArabyVirginia Commonwealth UniversityVerified email at vcu.edu
Abdel Nasser B.SingabFormer- Vice President for Postgraduate and Research - Ain Shams Uni- Chairman of Drug DiscoveryVerified email at pharma.asu.edu.eg
Vincenzo Di MarzoConsiglio nazionale delle RicercheVerified email at icb.cnr.it
Mai F. TolbaAssociate Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Tamer M. IbrahimAssociate Professor, Kafrelsheikh UniversityVerified email at pharm.kfs.edu.eg
Samia Shoumannational cancer institute, cairo universityVerified email at nci.cu.edu.eg
Heba Mohammed HeshamAin Shams universityVerified email at pharma.asu.edu.eg
Khaled BarakatUniversity of AlbertaVerified email at ualberta.ca

Khaled Abouzid

professor of pharmaceutical chemistry

Verified email at pharma.asu.edu.eg - Homepage

pharmaceutical and medicinal chemistry


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand AD Khanolkar, V Abadji, S Lin, WAG Hill, G Taha, K Abouzid, Z Meng, ... Journal of medicinal chemistry 39 (22), 4515-4519, 1996	207	1996
Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase W Lang, C Qin, S Lin, AD Khanolkar, A Goutopoulos, P Fan, K Abouzid, ... Journal of medicinal chemistry 42 (5), 896-902, 1999	160	1999
Synthesis of certain substituted quinoxalines as antimicrobial agents (part II) MM Badran, KAM Abouzid, MHM Hussein Archives of pharmacal research 26, 107-113, 2003	152	2003
Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents MA Aziz, RAT Serya, DS Lasheen, AK Abdel-Aziz, A Esmat, AM Mansour, ... Scientific reports 6 (1), 24460, 2016	140	2016
Design and Synthesis of New Tetrazolyl- and Carboxy-biphenylylmethyl-quinazolin-4-one Derivatives as Angiotensin II AT₁ Receptor Antagonists MAH Ismail, S Barker, DA Abou El Ella, KAM Abouzid, RA Toubar, ... Journal of medicinal chemistry 49 (5), 1526-1535, 2006	138	2006
Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase K Abouzid, S Shouman Bioorganic & Medicinal Chemistry 16 (16), 7543-7551, 2008	134	2008
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer HM Hesham, DS Lasheen, KAM Abouzid Medicinal Research Reviews 38 (6), 2058-2109, 2018	129	2018
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors AH Abadi, TM Ibrahim, KM Abouzid, J Lehmann, HN Tinsley, BD Gary, ... Bioorganic & medicinal chemistry 17 (16), 5974-5982, 2009	128	2009
Pyridazinone derivatives: Design, synthesis, and in vitro vasorelaxant activity K Abouzid, MA Hakeem, O Khalil, Y Maklad Bioorganic & medicinal chemistry 16 (1), 382-389, 2008	98	2008
Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer FM Elmenier, DS Lasheen, KAM Abouzid European journal of medicinal chemistry 183, 111718, 2019	93	2019
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective MAW Shalaby, EME Dokla, RAT Serya, KAM Abouzid European journal of medicinal chemistry 199, 112312, 2020	84	2020
Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis ZSBHJ Xin Ge, Min-Hong Pan, Lin Wang, Wei Li, Chengfei Jiang, Jun He, Khaled ... cell death and disease 9, 1128, 2018	82	2018
Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity K Abouzid, SA Bekhit Bioorganic & medicinal chemistry 16 (10), 5547-5556, 2008	80	2008
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold MI Shahin, DA Abou El Ella, NSM Ismail, KAM Abouzid Bioorganic Chemistry 56, 16-26, 2014	73	2014
Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities KAM Abouzid, GH Al-Ansary, AM El-Naggar European journal of medicinal chemistry 134, 357-365, 2017	71	2017
Quinoxaline‐based scaffolds targeting tyrosine kinases and their potential anticancer activity AMS El Newahie, NSM Ismail, DA Abou El Ella, KAM Abouzid Archiv der Pharmazie 349 (5), 309-326, 2016	67	2016
Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents EZ Elrazaz, RAT Serya, NSM Ismail, DA Abou El Ella, KAM Abouzid Future Journal of Pharmaceutical Sciences 1 (2), 33-41, 2015	63	2015
How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors SN Milik, DS Lasheen, RAT Serya, KAM Abouzid European Journal of Medicinal Chemistry 142, 131-151, 2017	55	2017
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ... European Journal of Medicinal Chemistry 186, 111850, 2020	53	2020
Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists SM Abou-Seri, K Abouzid, DA Abou El Ella European Journal of Medicinal Chemistry 46 (2), 647-658, 2011	51	2011

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors